Immunoassay News and Research

RSS
Mayo Clinic, Gentag, Fraunhofer IMS and NovioSense partner to combat type 2 diabetes worldwide

Mayo Clinic, Gentag, Fraunhofer IMS and NovioSense partner to combat type 2 diabetes worldwide

Omega-3 fatty acids and antioxidants may benefit people with Alzheimer's disease

Omega-3 fatty acids and antioxidants may benefit people with Alzheimer's disease

SeraCare Life Sciences inks CRADA with NCI to create positive controls for cancer assays

SeraCare Life Sciences inks CRADA with NCI to create positive controls for cancer assays

Sysmex unveils latest series of haematology analysers at IFCC congress

Sysmex unveils latest series of haematology analysers at IFCC congress

Beckman Coulter brings new thinking to new lab challenges at EuroMedLab 2015

Beckman Coulter brings new thinking to new lab challenges at EuroMedLab 2015

BiondVax invited to present at EDUFULVAC-NIAID workshop on immunoassay standardization for universal flu vaccines

BiondVax invited to present at EDUFULVAC-NIAID workshop on immunoassay standardization for universal flu vaccines

Ampio reports effects of Ampion in treating chronic pain caused by osteoarthritis of the knee

Ampio reports effects of Ampion in treating chronic pain caused by osteoarthritis of the knee

Aushon BioSystems announces commercial release of Ultrasensitive Cira Assays

Aushon BioSystems announces commercial release of Ultrasensitive Cira Assays

Verax Biomedical obtains FDA clearance to expand use of Verax Platelet PGD test

Verax Biomedical obtains FDA clearance to expand use of Verax Platelet PGD test

First CE marked FGF23 ELISA assay launched at Biomedica Immunoassays

First CE marked FGF23 ELISA assay launched at Biomedica Immunoassays

Bio-Rad grants Beckman Coulter exclusive distribution rights for access HIV and Hepatitis C assays

Bio-Rad grants Beckman Coulter exclusive distribution rights for access HIV and Hepatitis C assays

Study provides insights into basis for cognitive dysfunction

Study provides insights into basis for cognitive dysfunction

Vermillion announces total revenue of $1.6 million for fourth quarter 2014

Vermillion announces total revenue of $1.6 million for fourth quarter 2014

Immunomagnetic assay with microfluidic technology can capture, manipulate circulating tumor cells

Immunomagnetic assay with microfluidic technology can capture, manipulate circulating tumor cells

Astute Medical hails launch of collaborative global initiative to prevent deaths from AKI by 2025

Astute Medical hails launch of collaborative global initiative to prevent deaths from AKI by 2025

Serum testosterone may decline due to decreased sexual activity and desire in older men

Serum testosterone may decline due to decreased sexual activity and desire in older men

Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

Grifols, Alkahest sign definitive agreements

Grifols, Alkahest sign definitive agreements

Astute Medical previews upcoming AKI & CRRT 2015 conference to be held in San Diego

Astute Medical previews upcoming AKI & CRRT 2015 conference to be held in San Diego

Researchers develop smartphone accessory for rapid diagnosis of infectious diseases at point of care

Researchers develop smartphone accessory for rapid diagnosis of infectious diseases at point of care